Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

Clinical trial NCT06665997 · RECRUITING

Trial details

NCT number: NCT06665997
Sponsor: University of Pennsylvania
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sickle Cell Disease (SCD)Vaso-Occlusive Pain Episode in Sickle Cell Disease

Start date: 2025-06-26
Primary completion: 2028-07-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.